Core Laboratories (CLB) Balance Sheet: Assets & Liabilities

Core Laboratories (CLB) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Core Laboratories reported total assets of $584.01M and total liabilities of $311.80M. Shareholders' equity was $265.99M, up 7.9% from $246.57M a year earlier. Total debt stood at $164.02M against $22.70M in cash and short-term investments, a net debt position of $141.32M. That puts debt-to-equity at 0.62, compared with 0.55 a year earlier.

Core Laboratories Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Core Laboratories Inc. (CLB) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	22.70	19.16	15.12	15.43	17.70	13.81	11.09	13.12	14.40
Cash & Short-Term Investments	22.70	19.16	15.12	15.43	17.70	13.81	11.09	13.12	14.40
Accounts Receivable	120.80	111.76	109.35	115.10	96.83	83.19	138.11	129.16	133.10
Inventory	54.50	59.40	71.70	60.45	45.44	38.15	50.16	45.66	33.32
Other Current Assets	16.67	10.52	5.09	20.73	5.11	30.70	21.88	43.04	26.61
Total Current Assets	214.67	221.33	223.14	211.70	189.06	165.85	221.24	230.98	207.43
Non-Current Assets
Property, Plant & Equipment (Net)	153.79	153.55	153.47	157.41	172.34	181.68	199.20	122.92	123.10
Long-Term Investments	4.43	5.08	4.84	4.45	4.16	4.09	3.97	3.76	3.56
Goodwill	105.79	99.45	99.45	99.45	99.45	99.45	213.43	219.41	179.04
Intangible Assets	7.12	6.40	6.93	7.48	8.14	8.58	17.45	13.05	9.40
Other Non-Current Assets	30.84	29.71	29.38	29.30	37.26	36.16	52.08	-15.01	-14.28
Total Non-Current Assets	369.35	363.80	363.26	366.65	391.80	402.73	553.44	417.85	377.39
Total Assets	584.01	585.13	586.40	578.35	580.85	568.58	774.67	648.83	584.81
Current Liabilities
Accounts Payable	37.28	34.55	33.51	45.85	29.73	23.03	35.61	41.16	41.70
Short-Term Debt	11.46	10.69	10.18	11.70	12.34	11.44	11.84	0.00	0.00
Accrued Liabilities	26.53	22.90	18.79	28.25	20.83	-	-	-	-
Deferred Revenue	5.55	9.33	4.76	5.94	7.77	5.46	13.38	17.33	17.07
Other Current Liabilities	51.73	8.16	7.65	31.79	7.68	34.93	44.44	33.66	50.74
Total Current Liabilities	106.02	102.45	88.10	103.14	90.78	89.75	111.59	102.55	105.02
Non-Current Liabilities
Long-Term Debt	152.56	126.11	163.13	210.69	188.64	315.54	369.94	289.77	226.99
Deferred Tax Liabilities	8.00	9.07	12.70	22.88	24.34	20.59	27.34	7.63	5.32
Other Non-Current Liabilities	15.85	20.73	20.04	20.88	27.71	27.99	33.17	37.22	45.96
Total Non-Current Liabilities	205.79	230.37	268.49	286.27	329.07	403.26	480.94	385.38	331.06
Total Liabilities	311.80	332.81	356.59	389.40	419.85	493.01	592.53	487.93	436.08
Stockholders' Equity
Common Stock	0.47	0.47	0.47	1.19	1.19	1.15	1.15	1.15	1.15
Retained Earnings	172.66	144.86	120.76	85.95	68.35	50.46	160.54	156.13	173.86
Accumulated Other Comprehensive Income	0.00	-5.77	-4.97	-3.78	-10.13	-7.20	-6.33	-5.46	-8.35
Treasury Stock	11.59	2.54	1.45	1.36	4.08	-	-	-	-
Additional Paid-in Capital	0.00	109.55	110.01	100.89	101.12	27.11	22.51	4.94	-21.81
Minority Interest	6.22	5.75	4.99	4.70	4.55	4.06	4.28	4.14	3.89
Shares Outstanding	46.10	46.83	46.86	46.63	46.35	-	-	-	-
Total Stockholders' Equity	265.99	246.57	224.82	184.26	156.45	71.51	177.87	160.90	148.73
Total Liabilities & Equity	596.95	585.13	586.40	578.35	580.85	568.58	774.67	648.83	584.81

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Core Laboratories Balance Sheet

How much debt does Core Laboratories have?

Core Laboratories had total debt of $164.02M as of Dec 31, 2025, against $22.70M in cash and short-term investments. Its debt-to-equity ratio was 0.62. Total debt was $136.80M a year earlier.

What are Core Laboratories's total assets?

Core Laboratories reported total assets of $584.01M as of Dec 31, 2025, down 0.2% from $585.13M a year earlier. Total liabilities were $311.80M.

What is Core Laboratories's shareholders' equity?

Core Laboratories's shareholders' equity was $265.99M as of Dec 31, 2025, or about $5.77 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition